PT - JOURNAL ARTICLE AU - Yap, Ava AU - Halid, Salamatu I. AU - Ukwu, Nancy AU - Laverde, Ruth AU - Park, Paul AU - Klazura, Greg AU - Bryce, Emma AU - Cheung, Maija AU - Marseille, Elliot AU - Ozgediz, Doruk AU - Ameh, Emmanuel A. TI - Cost-Effectiveness of a Pediatric Operating Room Installation in Sub-Saharan Africa AID - 10.1101/2023.03.02.23286697 DP - 2023 Jan 01 TA - medRxiv PG - 2023.03.02.23286697 4099 - http://medrxiv.org/content/early/2023/03/06/2023.03.02.23286697.short 4100 - http://medrxiv.org/content/early/2023/03/06/2023.03.02.23286697.full AB - The unmet need for pediatric surgery incurs enormous health and economic consequences globally, predominantly shouldered by Sub-Saharan Africa (SSA) where children comprise almost half of the population. Lack of economic impact data on improving pediatric surgical infrastructure in SSA precludes informed allocation of limited resources towards the most cost-effective interventions to bolster global surgery for children. We assessed the cost-effectiveness of installing and maintaining a pediatric operating room in a hospital in Nigeria with a pre-existing pediatric surgical service by constructing a decision tree model of pediatric surgical delivery at this facility over a year, comparing scenarios before and after the installation of two dedicated pediatric operating rooms (ORs), which were funded philanthropically. Health outcomes measured in disability-adjusted life years (DALYs) averted were informed by the hospital’s operative registry and prior literature. A societal perspective included costs incurred by the hospital system, charity, and patients’ families. Costs were annualized and reported in 2021 United States dollars ($). The incremental cost-effectiveness ratios (ICERs) of the annualized OR installation were presented from charity and societal perspectives. One-way and probabilistic sensitivity analyses were performed. We found that the installation and maintenance of two pediatric operating rooms averted 1145 DALYs and cost $155,509 annually. Annualized OR installation cost was $87,728 (56% of the overall cost). The ICER of the OR installation was $152 per DALY averted (95% uncertainty interval [UI] 147-156) from the societal perspective, and $77 per DALY averted (95% UI 75-81) from the charity perspective. These ICERs were well under the cost-effectiveness threshold of the country’s half-GDP per capita in 2020 ($1043) and remained cost-effective in one-way and probabilistic sensitivity analyses. Installation of additional pediatric operating rooms in SSA with pre-existing pediatric surgical capacity is therefore very cost-effective, supporting investment in children’s global surgical infrastructure as an economically sound intervention.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Center of Health Equity of Surgery and Anesthesia at the University of California San Francisco, which funded the authors' stipend and analysis. No grants or commercial funding was involved.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Abuja National Hospital (NHA/EC/071/2019) and University of California San Francisco (19-29663) Institutional Review Board approvals were obtained for the purposes of this study.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data underlying this article are available in the article and in its online supplementary material.